| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.0048 | 0.9 |